Meridian Bioscience Reports Second Quarter 2019 Operating Results, Suspends Quarterly Cash Dividend, and Provides Fiscal 2019 Guidance for Pending Acquisition
Go back to Meridian Bioscience Reports Second Quarter 2019 Operating Results, Suspends Quarterly Cash Dividend, and Provides Fiscal 2019 Guidance for Pending Acquisition| Meridian Bioscience, Inc. (NASDAQ: VIVO) | Delayed: 5.87 +0.42 (7.71%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.45 | 52 Week High | $21.49 | |||
| Open | $5.51 | 52 Week Low | $15.75 | |||
| Day High | $6.24 | P/E | 6.67 | |||
| Day Low | $5.35 | EPS | $0.88 | |||
| Volume | 1,863,790 | |||||
